You just read:

Soligenix Announces Positive Long-Term Follow-up Results from its Phase 2 Clinical Trial of SGX942 for the Treatment of Oral Mucositis in Head and Neck Cancer Patients

News provided by

Soligenix, Inc.

Dec 08, 2016, 07:00 ET